Oratestin

Oratestin Brand names, Oratestin Analogs

Oratestin Brand Names Mixture

Aldactazide 25 (Hydrochlorothiazide + Spironolactone)
Aldactazide 50 (Hydrochlorothiazide + Spironolactone)
Apo-Spirozide Tab (Hydrochlorothiazide + Spironolactone)
Novo-Spirozine Tab 25mg (Hydrochlorothiazide + Spironolactone)
Novo-Spirozine-50 Tab (Hydrochlorothiazide + Spironolactone)

Oratestin Chemical_Formula

C₂₀H₂₉FO₃

Oratestin RX_link

http://www.rxlist.com/cgi/generic2/fluoxy.htm

Oratestin fda sheet

Oratestin msds (material safety sheet)

Oratestin MSDS

Oratestin Synthesis Reference

No information avaliable

Oratestin Molecular Weight

336.441 g/mol

Oratestin Melting Point

270 ^oC

Oratestin H₂O Solubility

67.5 mg/L

Oratestin State

Solid

Oratestin LogP

2.537

Oratestin Dosage Forms

Tablet

Oratestin Indication

In males, used as replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone. In females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.

Oratestin Pharmacology

Fluoxymesterone is a synthetic androgen, or male hormone, similar to testosterone. Fluoxymesterone works by attaching itself to androgen receptors; this causes it to interact with the parts of the cell involved in the making of proteins. It may cause an increase in the synthesis of some proteins or a decrease in the synthesis of others. These proteins have a variety of effects, including blocking the growth of some types of breast cancer cells, stimulating cells that cause male sexual characteristics, and stimulating the production of red blood cells.

Oratestin Absorption

Oral absorption is less than 44%.

Oratestin side effects and Toxicity

Side effects include virilization (masculine traits in women), acne, fluid retention, and hypercalcemia.

Oratestin Patient Information

Oratestin Organisms Affected

Humans and other mammals